HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mycobacterium marinum infection in an immunocompromised patient with infliximab.

AuthorsStephanie Zimmerlich, Ines B Eder, Jan C Simon, Manfred Kunz
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) Vol. 30 Issue 4 Pg. 436-437 (Aug 01 2020) ISSN: 1952-4013 [Electronic] France
PMID32969808 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Ethambutol
  • Infliximab
  • Clarithromycin
  • Rifampin
Topics
  • Anti-Inflammatory Agents (adverse effects)
  • Clarithromycin (administration & dosage)
  • Colitis, Ulcerative (drug therapy)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Ethambutol (administration & dosage)
  • Humans
  • Immunocompromised Host
  • Infliximab (adverse effects)
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous (drug therapy, immunology)
  • Rifampin (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: